STSSW Sharps Technology Inc.

Nasdaq Surgical & Medical Instruments & Apparatus NV CIK: 0001737995
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

Sharps Technology is operationally non-viable with revenue of $204.1K generating losses of $282.5M, indicating fundamental business failure or incomplete commercialization. Despite a solvent balance sheet, negative unit economics (-202.5% gross margin) and $11M annual cash burn demonstrate the company cannot sustain operations without dramatic operational restructuring or exogenous capital infusions.

Strengths

  • + No long-term debt provides financial flexibility and eliminates solvency risk
  • + Strong balance sheet with $264.4M stockholders equity and $10.4M cash reserves
  • + Positive current ratio of 4.02x indicates short-term liquidity to fund operations

Risks

  • ! Catastrophic operating losses of $269.7M on $204.1K revenue indicates failed unit economics or pre-commercial state
  • ! Negative gross margin of -202.5% demonstrates products lose money on every sale
  • ! Negative operating cash flow of -$11M annually with free cash flow of -$14.4M creates unsustainable burn trajectory

Key Metrics to Watch

Financial Metrics

Revenue
204.1K
Net Income
-282.5M
EPS (Diluted)
$-11.16
Free Cash Flow
-14.4M
Total Assets
269.1M
Cash
10.4M

Profitability Ratios

Gross Margin -202.5%
Operating Margin -132,145.5%
Net Margin -138,400.0%
ROE -106.9%
ROA -105.0%
FCF Margin -7,051.0%

Balance Sheet & Liquidity

Current Ratio
4.02x
Quick Ratio
3.88x
Debt/Equity
0.00x
Debt/Assets
1.7%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-16T19:45:22.896251 | Data as of: 2025-12-31 | Powered by Claude AI